T cell tumorigenesis in Lmo2 transgenic mice is independent of V-D-J recombinase activity.
The LMO2 gene is involved in T-cell acute leukaemia (T-ALL) in children with chromosomal translocations t(11;14)(p13;q11) or (7;11)(q35;p13). Transgenic expression of Lmo2 in T cells results in clonal tumours with long latency indicating that mutations in other genes are required for the development...
Main Authors: | Drynan, L, Hamilton, T, Rabbitts, T |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2001
|
Similar Items
-
An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions.
by: Nam, C, et al.
Published: (2008) -
The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development.
by: McCormack, M, et al.
Published: (2003) -
Null mutation of the Lmo4 gene or a combined null mutation of the Lmo1/Lmo3 genes causes perinatal lethality, and Lmo4 controls neural tube development in mice.
by: Tse, E, et al.
Published: (2004) -
Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia.
by: Appert, A, et al.
Published: (2009) -
The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice.
by: Yamada, Y, et al.
Published: (2000)